Among patients with NSCLC, those who responded to PD-1 therapy exhibited a higher proportion of circulating MAIT cells expressing the IFN-γ receptor (IFN-γR) in CD3+ T cells. Here, PDCD1 is linked to non-small cell lung carcinoma.